What is NeoGenomics (NEOus)?
NeoGenomics is a provider of cancer-focused genetic testing services and information to the medical community. The company offers a range of diagnostic tests, including molecular diagnostics, cytogenetics, and flow cytometry, to support cancer diagnosis, prognosis, and treatment decisions. NeoGenomics serves hospitals, pharmaceutical companies, and research institutions, contributing to precision medicine through advanced laboratory services. The company operates multiple laboratories and emphasizes quality and accuracy in its testing processes. Its services support oncologists and healthcare providers in delivering tailored cancer care.
NeoGenomics Stock Price Today: Live Overview
The price today is shaped by current trading sessions, as NeoGenomics trades at $7.93. The price has moved between $7.84 and $8.09, indicating a daily change of 0%.
FAQ: NeoGenomics (NEOus)
What is the current price of NEOus stock?
The closing price is $7.93.
Does NEOus pay dividends?
NeoGenomics pays dividends via cash distributions (if applicable).
Does NEOus have a formal corporate presence or regional headquarters in the UAE?
NeoGenomics does not have an official office or subsidiary in the UAE and operates via distributors.
What is NEOus best known for?
NeoGenomics is most famous for its cancer-focused genetic testing and diagnostic services.
What assets are typically shown together with NEOus?
Commonly shown alongside NEOus: Universal Health Services, Petco Health & Wellness Co Inc, Universal Health Services
Latest shares articles



